MGM Targets saw a need for development of a versatile, durable and economical target to better facilitate tactical / personal protection training while being mindful of the household budget. The ...
The latest price target for Century Therapeutics (NASDAQ:IPSC) was reported by Leerink Partners on November 17, 2025. The analyst firm set a price target for $2.00 expecting IPSC to rise to within 12 ...
UniXell Biotechnology Co., Ltd. ('UniXell') has secured Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for UX-DA003, its allogeneic induced pluripotent stem ...
Researchers across discovery and translational biomedicine recognize the critical importance of iPSCs in core applications beyond regenerative medicine. Large, global biobanks offer researchers ...
Shares of Century Therapeutics, Inc. (IPSC) have gained 9.7% over the past four weeks to close the last trading session at $5, but there could still be a solid upside left in the stock if short-term ...
Caldwell, Idaho – 26 January, 2016 –Regarded as the leader in steel target innovation and manufacturing for over 20 years, MGM Targets saw a need for development of a versatile, durable and economical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results